指南与共识

ESMO恶性淋巴瘤共识会议:超高危患者的管理

ESMO Consensus Conference on malignant lymphoma: management of 'ultra-high-risk' patients.
指南 / 共识 · Ann Oncol · 2018-01-01

ESMO于2015年6月20日在瑞士卢加诺召开恶性淋巴瘤共识会议,由25名多学科专家组成专家组。会议针对老年患者、适合临床使用的预后因素及超高危组三个领域制定推荐,本文呈现关于弥漫大B细胞淋巴瘤早期中枢神经系统复发、原发难治性霍奇金淋巴瘤和浆母细胞淋巴瘤管理的共识推荐。

要点

  • 共识聚焦于弥漫大B细胞淋巴瘤早期中枢神经系统复发的管理。
  • 共识涵盖原发难治性霍奇金淋巴瘤的处理推荐。
  • 共识包括浆母细胞淋巴瘤的管理建议。

核心结论

  • 专家组就弥漫大B细胞淋巴瘤早期中枢神经系统复发、原发难治性霍奇金淋巴瘤和浆母细胞淋巴瘤三种超高危情况的管理达成共识推荐。

研究设计与样本

  • ESMO共识会议于2015年6月20日在瑞士卢加诺举行,包含25名多学科专家。
  • 会前专家组分为三个工作组,分别聚焦老年患者、预后因素和超高危组,并预先回顾相关科学文献。
  • 会议期间各工作组制定推荐,提交全体多学科专家组并达成共识。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The European Society for Medical Oncology (ESMO) consensus conference on malignant lymphoma was held on 20 June 2015 in Lugano, Switzerland, and included a multidisciplinary panel of 25 leading experts. The aim of the conference was to develop recommendations on critical subjects difficult to consider in detail in the ESMO Clinical Practice Guidelines. The following areas were identified: (1) the elderly patient, (2) prognostic factors suitable for clinical use and (3) the 'ultra-high-risk' group. Before the conference, the expert panel was divided into three working groups; each group focused on one of these areas in order to address clinically relevant questions relating to that topic. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, each working group developed recommendations to address each of the questions devised by their group. These recommendations were then presented to the entire multidisciplinary panel and a consensus was reached. This manuscript presents recommendations regarding the management of the following 'ultra-high-risk' situations: (1) early central nervous system relapse of diffuse large B-cell lymphoma, (2) primary refractory Hodgkin lymphoma and (3) plasmablastic lymphoma. Results, including a summary of evidence supporting each recommendation, are detailed in this manuscript. All expert panel members approved this final article.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Hutchings M, Ladetto M, Buske C, et al. ESMO Consensus Conference on malignant lymphoma: management of 'ultra-high-risk' patients. Ann Oncol. 2018. PMID: 29924296. doi:10.1093/annonc/mdy167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。